Macquarie Group LTD Global Blood Therapeutics, Inc. Transaction History

Macquarie Group LTD

  • $90.3 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$32.4 - $68.18 $24,980 - $52,566
-771 Reduced 23.38%
2,527 $225,000
Q4 2021

Feb 11, 2022
SELL
$24.9 - $40.26 $2,813 - $4,549
-113 Reduced 3.31%
3,298 $97,000
Q3 2021

Nov 12, 2021
BUY
$25.48 - $37.34 $49,660 - $72,775
1,949 Added 133.31%
3,411 $87,000
Q2 2021

Aug 13, 2021
SELL
$32.46 - $43.42 $6,524 - $8,727
-201 Reduced 12.09%
1,462 $51,000
Q1 2021

May 14, 2021
SELL
$38.94 - $50.85 $20,054 - $26,187
-515 Reduced 23.65%
1,663 $68,000
Q4 2020

Feb 16, 2021
SELL
$37.65 - $63.77 $954,540 - $1.62 Million
-25,353 Reduced 92.09%
2,178 $94,000
Q3 2020

Nov 13, 2020
BUY
$52.76 - $74.49 $56,717 - $80,076
1,075 Added 4.06%
27,531 $1.52 Million
Q2 2020

Aug 11, 2020
BUY
$48.73 - $81.82 $133,081 - $223,450
2,731 Added 11.51%
26,456 $1.67 Million
Q1 2020

May 15, 2020
BUY
$41.72 - $87.2 $923,055 - $1.93 Million
22,125 Added 1382.81%
23,725 $1.21 Million
Q4 2019

Feb 14, 2020
BUY
$45.7 - $81.86 $73,120 - $130,976
1,600 New
1,600 $127,000
Q2 2018

Aug 14, 2018
SELL
$38.7 - $50.15 $996,021 - $1.29 Million
-25,737 Closed
0 $0
Q1 2018

May 11, 2018
BUY
$39.6 - $65.9 $1.01 Million - $1.68 Million
25,437 Added 8479.0%
25,737 $1.24 Million
Q4 2017

Feb 15, 2018
BUY
$29.7 - $45.7 $8,910 - $13,710
300
300 $12,000

Others Institutions Holding GBT

# of Institutions
8
Shares Held
288K
Call Options Held
0
Put Options Held
0
View Full List

About Global Blood Therapeutics, Inc.

GBT Quotes by TradingView
  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email